Still, as HLRCC tumours are rare and there is a lack of genetic information, it is unknown whether these oncogenic events occur due to additional genetic mutations, or if they are a direct consequence of FH loss. The gene discussed is FH; the disease is hereditary leiomyomatosis and renal cell cancer.